Asarina Pharma ApS: Financial statements 2021
CVR: 38495712
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Asarina Pharma ApS (CVR 38495712) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -887,274 and a net result of DKK -24,704,716 compared with DKK -51,528,246 the year before. Equity in the 2021 report amounted to DKK 48,991,408. The solvency ratio was 96.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -887,274
- Profit/Loss
- DKK -24,704,716
- Equity
- DKK 48,991,408
- Total Assets
- DKK 50,679,441
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -887 t. | -24.7 mio. | 49 mio. | 1 |
| 2020 | - | -1.9 mio. | -51.5 mio. | 44.1 mio. | 2 |
| 2019 | - | -1.4 mio. | -52.4 mio. | 51.1 mio. | 3 |
| 2018 | - | -891.9 mio. | -31.3 mia. | 12.1 mia. | - |
Official annual report
Find more companies like Asarina Pharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Asarina Pharma ApS has published its annual report for 2020. Gross profit came to DKK -1,890,785, and the net result was DKK -51,528,246.
About Asarina Pharma ApS
Asarina Pharma ApS was a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2017. The company has been dissolved on 30 June 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Asarina Danmark ApS. The company has 1 employee (2025). In 2024, the company reported a gross profit of DKK -365,453 and a net result of DKK -1,333,232 compared with DKK -42,903,193 the year before. Equity in the 2024 report amounted to DKK -107,343.